title: A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients.
abstract: BACKGROUND
  A single-center study of 655 nonsensitized recipients of primary cadaveric kidney grafts is presented.
  
  
  RESULTS
  Graft survival in serologically HLA-DR 1-10 antigen-matched grafts to nonsensitized recipients at 1 year was 90%, compared with 82% (P=0.004) and 73% (P=0.001) in one and two DR antigen-mismatched grafts. The corresponding figures at 5 years were 76%, 62%, and 56%, respectively. Matching for the DR antigens 11-14, or for some DR alleles only detectable by genomic typing, further improved graft survival, but the differences did not reach statistical significance. Matching also for the serologically defined HLA-A and -B antigens did not significantly further improve overall graft survival, but some effects for grafts surviving at least 1 year were observed. Among recipients of grafts mismatched for zero, one, or two HLA-DR antigens, acute rejection episodes were experienced in 48%, 64% (P<0.001), and 82% (P<0.001), respectively, within the first 3 months. HLA-A and -B mismatches showed no significant correlation to acute rejection episodes.
  
  
  CONCLUSIONS
  Matching for the DR antigens 1-10 significantly secures and prolongs the survival of first cadaveric renal grafts. Our results also show that DR 1-10 antigen-matched combinations can often be obtained even in rather small recipient pools, when actively sought for.
authors.affiliation: Institute of Transplantation Immunology, Medical Department B, The National Hospital, Oslo, Norway.
authors.forename: A V
authors.initials: AV
authors.lastname: Reisaeter
authors.forename: T
authors.initials: T
authors.lastname: Leivestad
authors.forename: F
authors.initials: F
authors.lastname: Vartdal
authors.forename: A
authors.initials: A
authors.lastname: Spurkland
authors.forename: P
authors.initials: P
authors.lastname: Fauchald
authors.forename: I B
authors.initials: IB
authors.lastname: Brekke
authors.forename: E
authors.initials: E
authors.lastname: Thorsby
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology*; D006085:Graft Survival / Q000276:immunology*; D006684:HLA-DR Antigens / Q000276:immunology*; D006801:Humans; D007121:Immunocompetence; D007223:Infant; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D013997:Time Factors
chemical_list: D006684:HLA-DR Antigens